Association of TLR-4 mutations in host and donor cells and the risk for acute GVHD after allogeneic hematopoietic stem cell transplantation.

被引：0
|
作者：
Imado, Takehito [1 ]
Iwasaki, Tsuyoshi [1 ]
Kuroiwa, Takanori [1 ]
Kitano, Sachie [1 ]
Sano, Hajime [1 ]
Ogawa, Hiroyasu [1 ]
机构：
[1] Hyogo Med Univ, Nishinomiya, Hyogo, Japan
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3235.3235
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3235
引用
收藏
页码：923A / 923A
页数：1
相关论文
共 50 条
  • [31] ROLE of Fecal Calprotectin as BIOMARKER of Gvhd AFTER Allogeneic STEM CELL TRANSPLANTATION.
    Metafuni, Elisabetta
    Chiusolo, Patrizia
    Bellesi, Silvia
    Giammarco, Sabrina
    Marietti, Sara
    Zuppi, Cecilia
    Fanali, Chiara
    Castagnola, Massimo
    Leone, Giuseppe
    Sica, Simona
    BLOOD, 2010, 116 (21) : 537 - 537
  • [32] Lung epithelial cells of donor origin after allogeneic hematopoietic stem cell transplantation
    Mattsson, J
    Jansson, M
    Wernersson, A
    Barkholt, L
    Hassan, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S248 - S248
  • [33] Definition of myeloid engraftment after allogeneic hematopoietic stem cell transplantation.
    Rihn, C
    Cilley, J
    Monreal, J
    Gordon, L
    Singhal, S
    Tallman, M
    Williams, S
    Winter, J
    Mehta, J
    BLOOD, 2002, 100 (11) : 417A - 418A
  • [34] Chronic kidney disease after allogeneic hematopoietic stem cell transplantation.
    Abboud, Imad
    Socie, Gerard
    Porcher, Raphael
    Letavernier, Emmanuel
    Pillebout, Evangeline
    Lefaucheur, Carmen
    Glotz, Denis
    Peraldi, Marie-Noelle
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 420 - 420
  • [35] Origin of marrow microenvironment after allogeneic hematopoietic stem cell transplantation.
    Carlo-Stella, C
    Cilloni, D
    Sammarelli, G
    Falzetti, F
    Rizzoli, V
    Aversa, F
    Martelli, MF
    Tabilio, A
    BLOOD, 1999, 94 (10) : 132A - 132A
  • [36] Lung function after autologous and allogeneic hematopoietic stem cell transplantation.
    Krauth, KA
    Schuster, A
    Beyer, N
    Laws, HJ
    Nürnberger, W
    Burdach, SEG
    Göbel, U
    BONE MARROW TRANSPLANTATION, 1999, 23 : S128 - S128
  • [37] Tacrolimus vs cyclosporine for prevention of acute graft-vs-host disease (GVHD) after allogeneic blood stem cell transplantation.
    Przepiorka, D
    Ippoliti, C
    Khouri, I
    Anderlini, P
    Stein, L
    vanBesien, K
    Mehra, R
    Giralt, S
    Gajewski, J
    Fritsche, H
    Deisseroth, AB
    Cleary, K
    Champlin, R
    Andersson, B
    Korbling, M
    BLOOD, 1995, 86 (10) : 1568 - 1568
  • [38] Treatment difficulty with acute GVHD - frequent cause of mortality after allogeneic hematopoietic stem cell transplantation
    Lukas, J.
    Bojtarova, E.
    Mistrik, M.
    Bujdak, J.
    Sopko, L.
    Hatalova, A.
    Martisova, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2014, 115 (02): : 80 - 82
  • [39] Late Onset Acute GVHD (late aGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
    Omer, Aazim
    Weisdorf, Daniel J.
    Lazaryan, Aleksandr
    Shanley, Ryan
    Blazar, Bruce R.
    MacMillan, Margaret L.
    Brunstein, Claudio
    Bejanyan, Nelli
    Arora, Mukta
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S341 - S342
  • [40] Peripheral blood dendritic cells in patients with acute graft versus host disease after allogeneic hematopoietic cell transplantation.
    Pihusch, M
    Böck, SH
    Heller, T
    Schoch, C
    Haferlach, T
    Burkard, R
    Diem, H
    Pihusch, R
    Hiller, E
    Hiddemann, W
    Kolb, HJ
    BLOOD, 2001, 98 (11) : 204A - 204A
12345